plasma cell disorder treatment
Báo cáo y học: "Special considerations in the treatment of patients with bipolar disorder and medical co-morbidities"
Ngày tải lên :
25/10/2012, 10:51
... Access
Review
Special considerations in the treatment of patients with bipolar
disorder and medical co-morbidities
Kimberly D McLaren and Lauren B Marangell*
Address: Mood Disorders Center, Menninger Department ... medical
comorbidities in bipolar disorder, including those that are
treatment emergent, and to offer guidance to clinicians
regarding effective monitoring and treatment.
Material and methods
An ... are
indicated for use in bipolar disorder by the US Food and
Drug Administration (FDA). Aripiprazole has recently
been submitted to the FDA for approval in the treatment
of bipolar disorder. Other agents...
- 10
- 709
- 0
Báo cáo y học: "Line bisection performance in patients with generalized anxiety disorder and treatment-resistant depressionLine bisection performance in patients with generalized anxiety disorder and treatment-resistant depression"
Ngày tải lên :
26/10/2012, 08:57
... & Ladouceur R. Cognitive process of generalized
anxiety disorder in comorbid generalized anxiety disorder and
major depressive disorder. J Anx Disord. 2008; 22: 505-514.
20. Zuckerman M, ... were gender-balanced. Secondly, we did not
measure the disordered personality traits in our sub-
jects, since the dependent personality disorder pa-
tients have shown a pronounced leftward line ... neuroimaging and electro-
physiological data have also shown that patients with
anxiety disorders (e.g., panic disorder) displayed
lower activation of the left parietal or superior tem-
poral cortex,...
- 8
- 572
- 0
Tài liệu Treatment Guidelines for Children and Adolescents With Bipolar Disorder: Child Psychiatric Workgroup on Bipolar Disorder doc
Ngày tải lên :
12/02/2014, 19:20
... psychiatric disorders, particularly ADHD,
oppositional defiant disorder, conduct disorder, anxiety
disorder, and, during adolescence, substance abuse. In
this section, the treatment of these comorbid disorders
is ... weeks of treatment may be re-
quired to assess the effectiveness of the particular
psychotropic agent.
Treatment Algorithms
Two treatment- specific algorithms were developed
for acute phase treatment ... 2005
lww/chi/90680/CHI57088
Anxiety Disorders
Comorbid anxiety disorders can be treated using
psychotherapy and/or pharmacological interventions.
Among the psychosocial treatments, CBT has been
found efficacious for the treatment...
- 23
- 690
- 0
Hydroxyurea for the Treatment of Sickle Cell Disease docx
Ngày tải lên :
05/03/2014, 10:20
... of hydroxyurea treatment
for patients who have sickle cell disease?
2. What is the effectiveness (in everyday practice) of hydroxyurea treatment for patients
who have sickle cell disease?
3. ... effectiveness of hydroxyurea treatment of hematologic diseases, the toxicity
of hydroxyurea in the treatment of any disease, and the barriers to the treatment of sickle cell
disease with hydroxyurea ... needs?
a
Sickle cell disease is a genetic disorder that decreases life expectancy by 25 to 30 years and
affects approximately 80,000 Americans. Individuals are diagnosed with sickle cell disease...
- 298
- 1.1K
- 0
Enhancement-Mode Metal Organic Chemical Vapor Deposition-Grown ZnO Thin-Film Transistors on Glass Substrates Using N2O Plasma Treatment docx
Ngày tải lên :
05/03/2014, 21:20
... N
2
O plasma treatment for different durations
In order to determine the effect of the duration of N
2
O
plasma treatment on device characteristics, as-fabricated
ZnO TFTs were subjected to N
2
O plasma ... TFTs
following N
2
O plasma treatment, ZnO sample s were
characterized by the XRD, PL, and XPS methods. Two
ZnO samples, namely an as-grown sample and a sample
subjected to N
2
O plasma treatment for ... Conclusions
The postfabrication N
2
O plasma treatment on the as-
fabricated MOCVD ZnO TFTs changed their device
operation from depletion-mode to enhancement-mode.
N
2
O plasma treatment also improved the...
- 7
- 438
- 0
Esophageal Cancer – Cell and Molecular Biology, Biomarkers, Nutrition and Treatment Edited by Ferdous Rastgar Jazii Published pdf
Ngày tải lên :
08/03/2014, 00:20
... CANCER –
CELL AND MOLECULAR
BIOLOGY, BIOMARKERS,
NUTRITION AND
TREATMENT
Edited by Ferdous Rastgar Jazii
Esophageal Cancer – Cell and Molecular Biology, Biomarkers, Nutrition and Treatment ... preventing cell cycle progression through the R-point
[27]. By definition restriction point (R-point) is a point or event in G1 of a cell cycle at which
cell becomes committed to progress cell cycle ... cancer cells
[7, 8]. Most growth factors are polypeptides that regulate numerous cellular responses,
notably cell proliferation. They exert their effects by binding to specific receptor on the cell...
- 256
- 855
- 1
Báo cáo khoa học: Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway pdf
Ngày tải lên :
16/03/2014, 01:20
... cells.
A
B
C D
Fig. 3. Morphine treatment increased intercellular O
2
·
)
and H
2
O
2
levels in SH-SY5Y cells. (A) Morphine (Mor) time-dependently induced
ROS generation. Cells were treated with 4 ... high-dose morphine treatment leads to
apoptotic cell death through a mitochondria-dependent
apoptotic pathway in SH-SY5Y cells. JNK plays a
pivotal role in morphine-induced cell apoptosis via
enhancement ... All experi-
ments were performed using logarithmically growing cells.
Cell viability assay
Cells were plated at a density of 1 · 10
4
cells per well in
96-well plates and incubated overnight, and...
- 15
- 244
- 0
KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) pdf
Ngày tải lên :
22/03/2014, 09:20
... stages 3–5 CKD stage 5D CKD stages 1–5T
Treatment to different targets of phosphorus; or treatment to
different targets of PTH
CKD stages 3–5, 5D, or 1–5T
Treatment targets
RCTs
a
000
NX25 per ... supplementation vs active or control medical treatment
CKD stages 3–5
Calcium
supplementation
RCTs
a,c
000
NX25 per arm (X10 per arm for bone biopsy)
F/U X6 months
Treatment vs placebo/active control
Bisphosphonates,
CKD ... smaller
estimates of treatment effects for clinical outcomes could be
discussed and referenced in the rationale. The ERT cautioned
against interpreting observational studies with smaller effect
sizes for treatments...
- 140
- 777
- 1
Ruta 6 selectively induces cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer doc
Ngày tải lên :
22/03/2014, 17:20
... cancer cells,
by either inducing cell death or preventing further proliferation;
b) to explore the molecular mechanism of cell death by Ruta
6 + Ca
3
(PO
4
)
2
treatment of brain cancer cells ... of Ruta 6-treated cells showed the
accumulation of more subdiploid cells in MGR1 glioma cancer
cells (40.8%) than in B-lymphoid cells (3%), suggesting that
more brain cancer cells were being killed ... selectively in the cancer cells and by
inducing cell proliferation in the normal cells. Although these
cancer cells showed different degrees of sensitivity to Ruta
treatment in vitro, the bulk...
- 8
- 670
- 0
T-CELL LEUKEMIA CHARACTERISTICS, TREATMENT AND PREVENTION potx
Ngày tải lên :
23/03/2014, 05:21
... the treatment of B -cell lymphoma improving the survival of patients
with B -cell lymphoma. Unlike B -cell lymphomas no monoclonal antibody has received a
similar indication for treatment of T -cell ... is
broadly expressed on other T-cells or hematopoietic cells, treatment will not only eliminate
the tumor cells, it will also cause depletion of functional T-cells allowing reactivation or
susceptibility ... the
treatment of T -cell lymphomas. [2] These include the histone deacetylase inhibitors voronistat
(Zolinza®) and romidepsin (Istodax®) approved for treatment of previously treated cutaneous
T-cell...
- 148
- 635
- 0